Epilepsy is a condition that affects the brain. When someone has epilepsy, it means they have a tendency to have epileptic seizures.

Anyone can have a one-off seizure, but this doesn’t always mean they have epilepsy. Epilepsy is usually only diagnosed if someone has had more than one seizure, and doctors think it is likely they could have more.

Epilepsy can start at any age and there are many different types. Some types of epilepsy last for a limited time and the person eventually stops having seizures. But for many people epilepsy is a life-long condition.

Medical Marijuana Efficacy

Marijuana, or more specifically the cannabinoid compound CBD, represents the most exciting development treating Epilepsy. CBD has neuroprotective anti-inflammatory effects, and is tolerated well in humans. It is now thought to have a strong capability in controlling seizures where other pharmaceutical AED’s have failed. It also can increase brain activity leading to improvements in speech, communication, physicality and overall quality of life. Furthermore CBD has none of the psychoactive properties of THC, as well as greatly reduced side effects in comparison with the AEDs.

CBD rich cannabis oils such as Charlotte’s Web (which has 0.2% THC content) has been used successfully in Colorado with children suffering from Dravet’s Syndrome – more often than not untreatable with AED’s.

CNN reported case of ‘Charlotte Figis’ is the most remarkable: in the space of 6 months Charlotte went from having an average of 300 seizures a month to one; went from being in a wheel chair and eating through a tube, to walking and feeding herself unaided and from a concoction of AED’s and pharmaceutical products to just cannabis oil.

This sensational news of CBD’s medical capabilities in the treatment of Epilepsy and its non-psychoactive properties have paved the way for medical cannabis legislation across the world.

A UK based pharmaceutical company, GW Pharmaceuticals currently have a CBD based product called Epidolex on trial for the treatment of Epilepsy in the USA and the UK.